Imaging for early stage breast cancer

So where are we moving?

We know more about patient selection from published trials on low risk for LR

LR risk steadily decreasing

better imaging, screening better surgery, margins better systemic therapy

Absolute gain from RT likely decreasing 5 yr risk of invasive contralateral breast cancer is 1-2%

Data supports that a LR in elderly pts does not predict distant failure and death from cancer